Consun Pharmaceutical Group Ltd (HKSE:01681) Share Price

Company Profile

Business description
Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Contact
71, Dongpeng Avenue
Eastern section
Guangzhou Economic and Technological Development
Guangzhou
CHN
T: +86 2082264529
https://www.chinaconsun.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,178

Recommended

These two ASX shares are trading at a discount to our fair value.

Morningstar | 24 February 2025

Board members step down over differences on the role of former CEO Richard White.

Roy van Keulen | 24 February 2025

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Matt Wacher | 21 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,498.00	62.10	-0.73%
CAC 40	8,090.99	63.52	-0.78%
DAX 40	22,425.93	138.37	0.62%
Dow JONES (US)	43,461.21	33.19	0.08%
FTSE 100	8,658.98	0.39	-0.00%
HKSE	23,227.63	113.98	-0.49%
NASDAQ	19,286.93	237.08	-1.21%
Nikkei 225	38,281.45	495.49	-1.28%
NZX 50 Index	12,307.27	224.45	-1.79%
S&P 500	5,983.25	29.88	-0.50%
S&P/ASX 200	8,251.90	56.30	-0.68%
SSE Composite Index	3,367.25	5.77	-0.17%